News

JAKARTA – For more than three decades, Dexa Group has consistently contributed to providing quality medicines for the Indonesian people through Obat Generik Berlogo/OGB (unbranded generics) Dexa. Today, OGB Dexa produces more than 2 billion units annually with over 140 SKUs to support the National Health Insurance (JKN) program. This…

JAKARTA — Globally, the condition long known as polycystic ovary syndrome (PCOS) is estimated to affect more than 170 million women, or approximately one in eight women of reproductive age. The vast prevalence and far-reaching impact of this condition led to a global consensus published in The Lancet in 2026,…

JAKARTA – Prof. Raymond Tjandrawinata, Professor of Molecular Pharmacology at Atma Jaya University and Molecular Pharmacologist at Dexa Group, has successfully completed his Doctor of Law degree at Universitas Pelita Harapan (UPH), graduating with the distinction of Summa Cum Laude His doctoral research brings together his expertise in pharmaceutical science and…

JAKARTA — The rapid growth of Artificial Intelligence (AI) and digital technology is driving significant shifts across the healthcare ecosystem—from drug discovery and clinical practice to doctor-patient dynamics. These transformations formed the core discussion at the 2026 Dexa Periodic Scientific Meeting (PERIXA), which carried the theme “Navigating the Bio-Digital Era…

JAKARTA – For 27 years, Stimuno has been an integral part of the health journey for Indonesian families. Since its debut in 1999, this natural immunomodulator medication has accompanied families across generations, helping maintain strong immune systems so the body is better prepared to face various health challenges. Stimuno's long…

SOUTH TANGERANG – A healthy lifestyle is more than a passing trend; it is an essential part of maintaining long-term quality of life. This message was at the heart of the Indonesia Wellness Festival (Wellfest) 2026, themed “The New Paradigm of Sustainable Living,” held from September 4–6, 2026, at Bintaro…

JAKARTA – Dexa Group is strengthening Indonesia’s national pharmaceutical ecosystem by empowering 413 farmers across 34 districts in 11 provinces to supply raw materials for medicines derived from Indonesia’s biodiversity. The Green Pharmacy initiative, one of the implementations of Dexa Group’s Right to Win strategy, has once again earned the…